BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12438112)

  • 1. Characterization of [(3)H]epibatidine binding to nicotinic receptors from bovine adrenal medulla.
    McKay DB; Free RB; Kaser DJ; McKay SB
    Ann N Y Acad Sci; 2002 Oct; 971():162-4. PubMed ID: 12438112
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
    Free RB; McKay DB
    Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
    Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
    Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
    Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
    Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P and epibatidine-evoked catecholamine release from fractionated chromaffin cells.
    Krause W; Michael N; Lübke C; Livett BG; Oehme P
    Eur J Pharmacol; 1997 Jun; 328(2-3):249-54. PubMed ID: 9218708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
    Vainio PJ; Tuominen RK
    Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress.
    Egea J; Rosa AO; Cuadrado A; García AG; López MG
    J Neurochem; 2007 Sep; 102(6):1842-1852. PubMed ID: 17540012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
    Caban AJ; Hama AT; Lee JW; Sagen J
    Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35.
    Wenger BW; Bryant DL; Boyd RT; McKay DB
    J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
    Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
    Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain cyclooxygenase and prostanoid TP receptors are involved in centrally administered epibatidine-induced secretion of noradrenaline and adrenaline from the adrenal medulla in rats.
    Shimizu T; Yokotani K
    Eur J Pharmacol; 2009 Mar; 606(1-3):77-83. PubMed ID: 19374850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning stimuli that augment chromaffin cell secretion.
    Tapia L; García-Eguiagaray J; García AG; Gandía L
    Am J Physiol Cell Physiol; 2009 Apr; 296(4):C792-800. PubMed ID: 19211912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epibatidine and pain.
    Traynor JR
    Br J Anaesth; 1998 Jul; 81(1):69-76. PubMed ID: 9771274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epibatidine. An old work principle rediscovered].
    Hecker T; Nieber K
    Med Monatsschr Pharm; 1999 Aug; 22(8):226-32. PubMed ID: 10481433
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
    Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
    Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of brain nicotinic acetylcholine receptors activates adrenomedullary outflow via brain inducible NO synthase-mediated S-nitrosylation.
    Higashi Y; Shimizu T; Yamamoto M; Tanaka K; Yawata T; Shimizu S; Zou S; Ueba T; Yuri K; Saito M
    Br J Pharmacol; 2018 Oct; 175(19):3758-3772. PubMed ID: 30007012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioligand binding characterization of neuronal nicotinic acetylcholine receptors.
    Anderson DJ
    Curr Protoc Pharmacol; 2008 Dec; Chapter 1():Unit1.8. PubMed ID: 22294217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic stimulation of catecholamine synthesis and tyrosine hydroxylase phosphorylation in cervine adrenal medullary chromaffin cells.
    Knowles PJ; Douglas SA; Bunn SJ
    J Neuroendocrinol; 2011 Mar; 23(3):224-31. PubMed ID: 21121973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for epibatidine selectivity at desensitized nicotinic receptors.
    Pennington RA; Gao F; Sine SM; Prince RJ
    Mol Pharmacol; 2005 Jan; 67(1):123-31. PubMed ID: 15496507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.